| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 35.61 | 0.26 (+0.74%) | 26.39 - 35.88 | 0.0 |
Market data as of 6:05PM 05/21/13. Quotes are delayed by at least 15 min.
The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. Generally speaking, the "life sciences" relate to maintaining or improving quality of life. It normally invests at least 25% of its total assets in the "life sciences" sector, which may include companies in the following industry groups: health care; pharmaceuticals; agriculture; cosmetics/personal care; and biotechnology.
| Total Return | 20.19% |
|---|---|
| Yield (Trailing 12 Mo.) | 0.00% |
| Expense Ratio | 1.86% |
| Front Load | None |
| Deferred Load | 1.00% |
| Minimum Investment | $2,500 |
| Management Tenure | 6 Years |
| Fund Inception | 07/06/2009 |
| Timeframe | JFNCX | S&P 500 | Health |
|---|---|---|---|
| 1 Month | 4.09% | 1.93% | 3.76% |
| 3 Month | 10.78% | 7.18% | 11.97% |
| Year-to-Date | 19.13% | 12.74% | 20.51% |
| 1 Year | 27.13% | 16.89% | 29.26% |
| 3 Year | 18.17% | 12.80% | 17.75% |
| 5 Year | 9.78% | 5.21% | 12.34% |
| 10 Year | 10.22% | 7.88% | 10.77% |
| Since Inception | 20.19% | 10.38% | -- |
| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 2.78% | |
| Healthcare | 94.39% | |
| Utilities | 0.00% | |
| Communication Services | 0.00% | |
| Energy | 0.00% | |
| Industrials | 0.00% | |
| Technology | 2.83% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 75.75 | 75.75 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 0.83 | 0.83 | ||
| Foreign Stock | -- | 21.31 | 21.31 | ||
| Foreign Bond | -- | 0.00 | 0.00 | ||
| Total | -- | 97.89 | 97.89 | ||
| Cash | -- | 1.17 | 1.17 | ||
| Total Net Assets | $1.04B |
|---|---|
| Total Stock Holdings | 71 |
| Total Bond Holdings | 0 |
| Valuation | JFNCX | Category Range |
|---|---|---|
| Price/Earnings | 20.82 | |
| Price/Book | 3.62 | |
| Price/Sales | 1.68 | |
| Price/Cash Flow | 14.70 | |
| Dividend Yield | 0.73 | |
| LT Earnings | 13.14 | |
| Historical Earnings | 12.87 | |
| Sales Growth | 13.43 | |
| Cash-Flow Growth | 4.98 | |
| Book-Value Growth | 13.64 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Avg | |
| Return | Avg |
| Pretax Return | 18.17% |
|---|---|
| Tax-adjusted Return | 17.90% |
| Tax Cost Ratio | 0.23% |
| Potential Cap Gains | 15.55% |
